ESTRO Guide 2019

CLINICALSESSION

INTERDISCIPLINARYSESSION

PHYSICSSESSION

RTTSESSION

RADIOBIOLOGYSESSION

BRACHYTHERAPYSESSION

YOUNGSCIENTISTS'SESSIONS

far are we? -

matter? -

region

JOINT SYMPOSIUM SYMPOSIUM DEBATE DEBATE SYMPOSIUM SYMPOSIUM SYMPOSIUM DEBATE - doctor A new era for

practice

MR-guided

SYMPOSIUM SYMPOSIUM SYMPOSIUM DEBATE SYMPOSIUM SYMPOSIUM PROFFERED PAPERS SYMPOSIUM Radiotherapy Glioma New detector

radiotherapyin the pelvic region

technical uncertainties, are the main barrier to widespread

Workload/clinic

MR-based treatment

logistics, and not

implementation of

Bladder filling - does it

TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE

Focus on the pelvic

Status on adaptive strategies in the pelvic region – how

adaptive radiotherapy

planning for prostate cancer

-

-

-

calculation -

TUESDAY 30 APRIL 2019 for radiotherapy with protons instead of photons How to select patients

Discussion

(anthropomorphic) phantoms

radiotherapy

Personalised phantoms through 3D printing

Phantoms in motion

Phantoms in particle therapy to verify Monte Carlo dose

MR linacs and QA phantoms

-

Update on commercial scintillators -

Multichannel film dosimetry -

-

-

-

practice of SRS and SBRT: Consensus guidelines and protocols

12:20 – 13:20

developments

closing debate

Developments in time- resolved detectors

era of new (multi-modality) imaging technology

Closing remarks

Development of MR

techniques focused on improved delineation

(Dual Energy CT, iterative reconstructions, metal artifact reduction etc).

How to handle clinical

inter-observer variation in contouring assessment

Implemention and

Update on compact graphite calorimeter for absolute

dosimetry measurements

Using novel CT imaging for delineation improvements

in RT: not only for the

Improving delineation

The future of margins in the

-

cancer -

-

-

alternative or addition to radiotherapy - radiosurgery

response

head and neck cancer treatment

management of brain metastases

p16+ oropharyngeal cancer: new disease, new staging – what about treatment? Predictive models in

multiple brain metastases Systemic treatment as

Whole brain irradiation with hippocampal avoidance Radiosurgery alone in

Integration of PET

imaging in radiation treatment planning

Immunotherapy in head

Controversies in the

and neck cancer – when and for whom, biomarkers of

New developments in

Integration of surgery and

treatment of head and neck

radiotherapy tolerance from the REQUITE Consortium

the esophagus no longer need surgery

that there is still a role for radiotherapy in pancreatic cancer

This house believes that patients with

This house believes

Recent insights into

squamous cell cancer of

-

-

-

in glioma

Mechanisms of

The role of DNA replication stress in glioma stem cell radiation resistance

that immunotherapy is really changing

Chemoresistance related RNAs in glioblastoma

can the DNA damage response deliver a

Irradiation and targeted inhibition of the PI3K/

radiation oncology

This house believes

Hypofractionation:

Tumour cell connections

biological rationale?

AKT and MAPK pathways

radiation resistance in

causing radiation treatment

-

-

-

-

strategies -

young adults (AYA) a specific patients’ population?

MRI online ART:

Online adaptive planning in pancreatic cancer

Uncertainties in single fraction treatment

Future developments in adaptive strategies

Criteria for choosing dose and irradiation technique in severe conditions for palliation tretment

palliative patient - What`s the role of the RTT?

Palliation in RT - How much is enough?

Clinical results of PotD

Communication with a

Are adolescents and

Healthy tissue response to a single fraction treatment

opportunities and pitfalls

Plan of the day - present status and future aims

-

-

use?

The DNA damage response to radiotherapy: mechanisms

biomarkers: a

and therapeutic opportunities

to predict and monitor radiation response

Radiotherapeutical management of

New approaches to

ESTRO-RANZCR

genetics and pathology Advances in imaging

radiotherapy biomarkers, the data has gotten big

Translation of biomarker

signatures in daily clinical

confluence of imaging,

oligometastatic disease

10:30 – 11:00 COFFEE BREAK

08:30 – 09:10

12:20 – 13:20

09:15 – 10:30

11:00-12:15

140

CONFERENCES